Deutsche Bank’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-25,416
Closed -$55K 4480
2021
Q1
$55K Sell
25,416
-2,262
-8% -$4.9K ﹤0.01% 4117
2020
Q4
$62K Buy
27,678
+7,474
+37% +$16.7K ﹤0.01% 3973
2020
Q3
$54K Buy
20,204
+1,796
+10% +$4.8K ﹤0.01% 3787
2020
Q2
$56K Buy
18,408
+4,582
+33% +$13.9K ﹤0.01% 3703
2020
Q1
$28K Sell
13,826
-7,464
-35% -$15.1K ﹤0.01% 3709
2019
Q4
$60K Buy
21,290
+9,406
+79% +$26.5K ﹤0.01% 3779
2019
Q3
$42K Sell
11,884
-18,290
-61% -$64.6K ﹤0.01% 3894
2019
Q2
$124K Sell
30,174
-30,580
-50% -$126K ﹤0.01% 3979
2019
Q1
$309K Buy
+60,754
New +$309K ﹤0.01% 3673
2018
Q3
Sell
-1,300
Closed -$8K 4902
2018
Q2
$8K Sell
1,300
-1,300
-50% -$8K ﹤0.01% 4759
2018
Q1
$12K Buy
2,600
+2,598
+129,900% +$12K ﹤0.01% 4666
2017
Q4
$0 Hold
2
﹤0.01% 4460
2017
Q3
$0 Sell
2
-100
-98% ﹤0.01% 4396
2017
Q2
$0 Buy
102
+100
+5,000% ﹤0.01% 4494
2017
Q1
$0 Hold
2
﹤0.01% 4462
2016
Q4
$0 Hold
2
﹤0.01% 4456
2016
Q3
$0 Sell
2
-11
-85% ﹤0.01% 4521
2016
Q2
$0 Sell
13
-1,498
-99% ﹤0.01% 4774
2016
Q1
$2K Sell
1,511
-3,975
-72% -$5.26K ﹤0.01% 4646
2015
Q4
$8K Buy
5,486
+3,986
+266% +$5.81K ﹤0.01% 4518
2015
Q3
$3K Sell
1,500
-1,958
-57% -$3.92K ﹤0.01% 4591
2015
Q2
$9K Buy
3,458
+867
+33% +$2.26K ﹤0.01% 4596
2015
Q1
$8K Sell
2,591
-28,919
-92% -$89.3K ﹤0.01% 4385
2014
Q4
$109K Sell
31,510
-163
-0.5% -$564 ﹤0.01% 4370
2014
Q3
$158K Buy
31,673
+86
+0.3% +$429 ﹤0.01% 3994
2014
Q2
$435K Buy
31,587
+28,441
+904% +$392K ﹤0.01% 3466
2014
Q1
$48K Buy
+3,146
New +$48K ﹤0.01% 4529